Skip Navigation

Correction for Garber, J. Natl. Cancer Inst. 97 (15) 1112-1114.
JNCI Journal of the National Cancer Institute 2005 97(17):1247; doi:10.1093/jnci/dji302
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Correction

A news story in the August 3 issue ("New Drugs Target Hypoxia Response in Tumors," Vol. 97, No. 15, p. 1112) incorrectly attributed the first identification of the HIF-1 transcription factor. Gregg Semenza, M.D., Ph.D., of Johns Hopkins Medical School, and his laboratory discovered HIF-1 in 1992. The laboratories of Semenza, Peter Ratcliffe, M.D., and Jaime Caro, M.D., each reported the identification of the hypoxia response element on the EPO gene in 1991.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?